Celebrating 15 years
of driving innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology. We provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

12
Mar

12. March 2024 to 14. March 2024 — Register Here

DIA Europe 2024 – Collaborating for Healthcare Innovation – a focus on Sustainability!

DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2024 will be the prime opportunity to discuss how collaboration… read more

12
Mar

12. March 2024 to 13. March 2024 — Register here

World EPA Congress

The world-leading healthcare evidence, pricing, and access congress is taking place in Amsterdam in 2024. The main topics that will be covered during the event are the following: Market Access, Rare Diseases, Evidence, Pricing, Emerging Markets, HTA/Payers, Advanced Therapies, Health Economics & Outcomes Research, Patient… read more

19
Mar

19. March 2024 to 20. March 2024 — Register Here

Advanced Therapies Congress 2024

The Future of Advanced Therapies 19th-20th March – ExCel, London The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators. New for 2024: Gene Editing… read more

16
Apr

16. April 2024 — Register here

RARE DISEASES FORUM 2024: Securing Europe’s competitiveness in R&D for people living with rare diseases

Against the backdrop of the Belgian EU Council Presidency, the forum will bring together senior leaders from across patient organisations, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda and strengthen the case for EU… read more

15
May

15. May 2024 to 16. May 2024 — Registration Details

European Conference on Rare Diseases & Orphan Products (ECRD 2024)

Action Within Reach: Pioneering Solutions for Rare Diseases. The European Conference on Rare Diseases & Orphan Products (ECRD) is the largest, patient-led policy-shaping conference for rare diseases taking place in Europe. ECRD is an instrumental tool to achieve policy objectives for people living with a… read more

News & Updates

EUCOPE Member Spotlight: Q&A with Chiesi GRD

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more

Job Opening: European Genomics Project Manager

We are looking for a dedicated and experienced ‘Project Manager’ to support a multi-stakeholder genomics coalition at the EU level In this role you will provide the Secretariat function for a newly established multi-stakeholder coalition at the EU level, the European Coalition for Access to… read more

Job Opening: Communications & Business Development Manager

We are looking to recruit a dynamic and experienced Communications & Business Development Manager to shape and implement our communication strategies, grow the organisation and develop new partnership opportunities Location: On-site Job type: Full time Responsibilities: Developing and coordinating external and internal communications strategies; Drafting… read more

EVENT RECAP – Life Science Lectures: Episode Four “Leveraging early advice opportunities in EU HTA”

On 14 December, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the fourth episode of its #LifeScienceLectures webinar series.  The focus of the webinar, titled “Leveraging early advice opportunities in EU HTA” was to discuss how best to navigate early advice opportunities with the new… read more

EUCOPE Member Spotlight: Q&A with Blueprint Medicines

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In November, we spoke with Kenneth Saké – Vice President of International Medical Affairs, Blueprint Medicines. Tell us about… read more

Stakeholder coalition calls for legislative refinement of the EHDS

4 December 2023, Brussels – EUCOPE, as part of a large multi-stakeholder group, representing the entire spectrum of the healthcare ecosystem and consisting of 36 European patient organisations, medical associations, health research infrastructures and health industry associations, have issued a joint statement to alarm bells… read more

9 new members join EUCOPE network in October 2023

The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 9 new members at its quarterly Members Meeting on October 18th, 2023 following Board approval. The new members joining the EUCOPE network are Angelini Pharma, Dipharma, Italfarmaco, Labcorp, Metriopharm AG, Otsuka, Pharming Group, Pharvaris… read more

EUCOPE Member Spotlight: Q&A with Deciphera

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Margarida Duarte, Senior Vice President, Head of International, Deciphera Pharmaceuticals. Margarida Duarte is Senior… read more

EUCOPE Member Spotlight: Q&A with SKC Consulting

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Heike Kielhorn, Managing Partner from SKC. Heike Kielhorn-Schönermark studied business administration and economics in… read more

EUCOPE Member Spotlight: Q&A with Cevidra

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Francois Lontrade, Directeur General, Laboratoire Cevidra. Before joining Cevidra, Francois Lontrade gained 18 years’… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership